Proarrhythmic risk assessment using conventional and new in vitro assays.
Goineau, Sonia
Proarrhythmic risk assessment using conventional and new in vitro assays. [electronic resource] - Regulatory toxicology and pharmacology : RTP Aug 2017 - 1-11 p. digital
Publication Type: Journal Article
1096-0295
10.1016/j.yrtph.2017.05.012 doi
Action Potentials--drug effects
Anti-Arrhythmia Agents--toxicity
Arsenic--toxicity
Dose-Response Relationship, Drug
Drug Discovery
Drug Evaluation, Preclinical--methods
Fluoroquinolones--toxicity
Humans
In Vitro Techniques
Induced Pluripotent Stem Cells--drug effects
Long QT Syndrome--chemically induced
Moxifloxacin
Myocytes, Cardiac--drug effects
Pentamidine--administration & dosage
Phenethylamines--toxicity
Risk Assessment
Sulfonamides--toxicity
Proarrhythmic risk assessment using conventional and new in vitro assays. [electronic resource] - Regulatory toxicology and pharmacology : RTP Aug 2017 - 1-11 p. digital
Publication Type: Journal Article
1096-0295
10.1016/j.yrtph.2017.05.012 doi
Action Potentials--drug effects
Anti-Arrhythmia Agents--toxicity
Arsenic--toxicity
Dose-Response Relationship, Drug
Drug Discovery
Drug Evaluation, Preclinical--methods
Fluoroquinolones--toxicity
Humans
In Vitro Techniques
Induced Pluripotent Stem Cells--drug effects
Long QT Syndrome--chemically induced
Moxifloxacin
Myocytes, Cardiac--drug effects
Pentamidine--administration & dosage
Phenethylamines--toxicity
Risk Assessment
Sulfonamides--toxicity